In vivo bone augmentation in an osteoporotic environment using bisphosphonate-loaded calcium deficient apatite.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Biomaterials

• Publication date

  2010-10-01

• Fields of study

  Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1016/j.biomaterials.2010.06.047PMID 20643480
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Augmentation with silicone stabilizes proximal femur fractures: an in vitro biomechanical study.

  2009cited by this paper
• Locally delivered bisphosphonate for enhancement of bone formation and implant fixation.

  2009cited by this paper
• Long-term clinical outcomes following the use of synthetic hydroxyapatite and bone graft in impaction in revision hip arthroplasty.

  2009cited by this paper
• Prediction of bone density around orthopedic implants delivering bisphosphonate.

  2009cited by this paper
• Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro.

  2009cited by this paper
• Low bone mineral density and fracture burden in postmenopausal women

  2008cited by this paper
• Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women

  2008cited by this paper
• Low incidence of anti-osteoporosis treatment after hip fracture.

  2008cited by this paper
• Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot study.

  2008cited by this paper
• Reaction of Zoledronate with β-Tricalcium Phosphate for the Design of Potential Drug Device Combined Systems

  2008cited by this paper
• Fracture Outcomes Related to Persistence and Compliance With Oral Bisphosphonates

  2008cited by this paper
• Calcium-deficient apatite synthesized by ammonia hydrolysis of dicalcium phosphate dihydrate: influence of temperature, time, and pressure.

  2007cited by this paper
• Femoroplasty--augmentation of the proximal femur with a composite bone cement--feasibility, biomechanical properties and osteosynthesis potential.

  2007cited by this paper
• A systematic review of persistence and compliance with bisphosphonates for osteoporosis

  2007cited by this paper
• Strategies to Reduce Risk of Fall‐Related Injuries in Rehabilitation Nursing

  2007cited by this paper
• Low bone mineral density and fracture burden in postmenopausal women

  2007cited by this paper
• Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats.

  2007cited by this paper
• Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis.

  2007cited by this paper
• An integrated approach: bisphosphonate management for the treatment of osteoporosis.

  2007cited by this paper
• Evidence based medicine and effective interventions of pharmacological therapy for the prevention of osteoporotic fractures.

  2007cited by this paper
• Prevention and treatment of glucocorticoid-induced osteoporosis

  2007cited by this paper
• Improving compliance and persistence with bisphosphonate therapy for osteoporosis.

  2006cited by this paper
• Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.

  2006cited by this paper
• Ibandronate: pharmacology and preclinical studies.

  2006cited by this paper
• Assessment of compliance with osteoporosis treatment and its consequences in a managed care population.

  2006cited by this paper
• Local delivery of bisphosphonate from coated orthopedic implants increases implants mechanical stability in osteoporotic rats.

  2006cited by this paper
• Calcium phosphate drug delivery system : influence of local zoledronate release on bone implant osteointegration

  2005cited by this paper
• How Many Women Have Osteoporosis?

  2005cited by this paper
• Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration.

  2005cited by this paper
• Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women

  2005cited by this paper
• Prevention and treatment of glucocorticoid-induced osteoporosis in 2005.

  2005cited by this paper
• Novel biomaterials for bisphosphonate delivery.

  2005cited by this paper
• Hybrid materials applied to biotechnologies: coating of calcium phosphates for the design of implants active against bone resorption disorders

  2005cited by this paper
• Compliance with drug therapies for the treatment and prevention of osteoporosis.

  2004cited by this paper
• Prevention of trabecular bone loss in the mandible of ovariectomized rats.

  2004cited by this paper
• The ovariectomized sheep as a model for human bone loss.

  2004cited by this paper
• Femoroplasty-augmentation of mechanical properties in the osteoporotic proximal femur: a biomechanical investigation of PMMA reinforcement in cadaver bones.

  2004cited by this paper
• Chemically Modified Calcium Phosphates as Novel Materials for Bisphosphonate Delivery

  2004cited by this paper
• Preventive effects of sequential treatment with alendronate and 1 alpha-hydroxyvitamin D3 on bone mass and strength in ovariectomized rats.

  2003cited by this paper
• Prevention of Bone Loss in Ovariectomized Rats by Combined Treatment With Risedronate and 1α,25‐Dihydroxyvitamin D3

  2002cited by this paper
• Sequential hip fractures in elderly patients.

  2002cited by this paper
• Hip Fracture in Elderly Patients: Outcomes for Function, Quality of Life, and Type of Residence

  2001cited by this paper
• Effects of a New Selective Estrogen Receptor Modulator (MDL 103,323) on Cancellous and Cortical Bone in Ovariectomized Ewes: A Biochemical, Histomorphometric, and Densitometric Study

  2001cited by this paper
• In vivo effects of bisphosphonates on the osteoclast mevalonate pathway.

  2000cited by this paper
• Cellular and molecular mechanisms of action of bisphosphonates

  2000cited by this paper
• Prevalent Vertebral Deformities Predict Mortality and Hospitalization in Older Women with Low Bone Mass

  2000cited by this paper
• Prevention of hip fracture in elderly people with use of a hip protector.

  2000cited by this paper
• Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis

  2000cited by this paper
• Bisphosphonates in osteoporosis: recent clinical experience

  2000cited by this paper
• Bisphosphonates Act Directly on the Osteoclast to Induce Caspase Cleavage of Mst1 Kinase during Apoptosis

  1999cited by this paper
• Macroporous calcium phosphate ceramic: a prospective study of 106 cases in lumbar spinal fusion.

  1999cited by this paper
• Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography.

  1998cited by this paper
• Nitrogen‐Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post‐Translational Prenylation of GTP‐Binding Proteins, Including Ras

  1998cited by this paper
• The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials

  1998cited by this paper
• Synthetic porous ceramic compared with autograft in scoliosis surgery. A prospective, randomized study of 341 patients.

  1998cited by this paper
• The role of bisphosphonates in the treatment of osteoporosis

  1997cited by this paper
• Dose-response effects of estradiol implants on bone mineral density in ovariectomized ewes.

  1995cited by this paper
• Changes in bone mineral density and bone-specific alkaline phosphatase in ovariectomized ewes.

  1995cited by this paper
• Symptomatic fracture incidence in elderly men and women: The Dubbo osteoporosis epidemiology study (DOES)

  1994cited by this paper
• Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis.

  1993cited by this paper
• Determination of the Ca/P ratio in calcium-deficient hydroxyapatite using X-ray diffraction analysis

  1993cited by this paper
• Perspective how many women have osteoporosis?

  1992cited by this paper
• On the rat model of human osteopenias and osteoporoses.

  1992cited by this paper
• The ovariectomized rat model of postmenopausal bone loss.

  1991cited by this paper
• Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.

  1983cited by this paper
• Synthetic porous ceramic compared with autograft in scoliosis surgery

  year unknowncited by this paper

• Influence of the bisphosphonates alendronate, risedronate and zoledronic acid on the setting reaction of a hydroxyapatite-forming calcium phosphate cement

  2026cites this paper
• Characterization of Cortical Porosity in Patients With Cushing's Syndrome by High‐Resolution Computed Microtomography

  2025cites this paper
• Pilot Clinical Trial to Evaluate In Situ Calcium Phosphate Cement Injection for Conservative Surgical Management of Appendicular Osteosarcoma in Dogs

  2024cites this paper
• Calcium Phosphate Cements Combined with Blood as a Promising Tool for the Treatment of Bone Marrow Lesions

  2023cites this paper
• Physicochemical and cytological properties of poorly crystalline calcium-deficient hydroxyapatite with different Ca/P ratios

  2022cites this paper
• Research on Mechanism of Nanometric Bone Pulp Activated with Double Gene as Bone Morphogenetic Protein 1 and Vascular Endothelial Growth Factor for Improving the Strength of Centrum in Osteoporosis.

  2022cites this paper
• Advanced Glycation End Products, Bone Health, and Diabetes Mellitus.

  2022cites this paper
• Bisphosphonate-loaded bone cement: Background, clinical indications and future perspectives

  2022cites this paper
• Synergistic effect of Si-hydroxyapatite coating and VEGF adsorption on Ti6Al4V-ELI scaffolds for bone regeneration in an osteoporotic bone environment.

  2021cites this paper
• Suppression of osteoclastogenesis signalling pathways and attenuation of ameloblastic osteolysis induced by local administration of CaP-bisphosphonate and CaP-doxycycline cements: Review of the literature and therapeutic hypothesis

  2021cites this paper
• Local delivery systems of morphogens/biomolecules in orthopedic surgical challenges

  2021cites this paper
• Bisphosphonates, Old Friends of Bones and New Trends in Clinics.

  2021cites this paper
• Effect of zoledronic acid and graphene oxide on the physical and in vitro properties of injectable bone substitutes.

  2021cites this paper
• Nanocomposites in Drug Delivery and Imaging Applications

  2021cites this paper
• Bone Diseases: Current Approach and Future Perspectives in Drug Delivery Systems for Bone Targeted Therapeutics

  2020cites this paper
• Formation of 1-Hydroxymethylene-1,1-Bisphosphinates through the Addition of a Silylated Phosphonite on various Trivalent Derivatives.

  2020cites this paper
• Nanostructured calcium phosphates for hard tissue engineering and nanomedicine

  2020cites this paper
• Applications of extracellular vesicles in tissue regeneration.

  2020cites this paper
• From Industrial Method to the Use of Silylated P(III) Reagents for the Synthesis of Relevant Phosphonylated Molecules

  2020cites this paper
• The effect of two locally administered anti-resorptive agents on bone regeneration in a rat fibula model: Alendronate and 15-deoxy-Δ12,14-prostaglandin J2.

  2019cites this paper
• Microporous polysaccharide multilayer coated BCP composite scaffolds with immobilised calcitriol promote osteoporotic bone regeneration both in vitro and in vivo

  2019cites this paper
• 50 years of scanning electron microscopy of bone—a comprehensive overview of the important discoveries made and insights gained into bone material properties in health, disease, and taphonomy

  2019cites this paper
• Mesoporous bioactive glass/ɛ-polycaprolactone scaffolds promote bone regeneration in osteoporotic sheep.

  2019cites this paper
• Evaluating cortical bone porosity using Hr-Pqct

  2019cites this paper
• Gallium enhances reconstructive properties of a calcium phosphate bone biomaterial

  2018cites this paper
• Effect of nanoparticles of silver on redox status and the accumulation of Ag in chicken tissues.

  2018cites this paper
• The Effect of Administration of Silver Nanoparticles on the Immune Status of Chickens

  2018cites this paper
• Hydrogen sulfide epigenetically mitigates bone loss through OPG/RANKL regulation during hyperhomocysteinemia in mice.

  2018cites this paper
• Pain Management After Bone Reconstruction Surgery Using an Analgesic Bone Cement: A Functional Noninvasive In Vivo Study Using Gait Analysis.

  2018cites this paper
• Pollen-inspired microparticles with strong adhesion for drug delivery

  2018cites this paper
• Bisphosphonate Functionalized Gadolinium Oxide Nanoparticles Allow Long‐Term MRI/CT Multimodal Imaging of Calcium Phosphate Bone Cement

  2018cites this paper
• Bioceramics as drug delivery systems

  2018cites this paper
• Spray‐congealed solid lipid microparticles as a new tool for the controlled release of bisphosphonates from a calcium phosphate bone cement

  2018cites this paper
• Comparison of the effect of dietary copper nanoparticles and one copper (II) salt on the copper biodistribution and gastrointestinal and hepatic morphology and function in a rat model

  2018cites this paper
• Calcium Phosphates as Delivery Systems for Bisphosphonates

  2018cites this paper
• Preclinical and Translational Studies in Small Ruminants (Sheep and Goat) as Models for Osteoporosis Research

  2018cites this paper
• Osteogenic differentiation potential of adipose‐derived stem cells from ovariectomized mice

  2017cites this paper
• Enhanced bone formation by strontium modified calcium sulfate hemihydrate in ovariectomized rat critical-size calvarial defects

  2017cites this paper
• Systematic comparison of biologically active foreign ions-codoped calcium phosphate microparticles on osteogenic differentiation in rat osteoporotic and normal mesenchymal stem cells

  2017cites this paper
• The transpedicular surgical approach for the development of intervertebral disc targeting regenerative strategies in an ovine model

  2017cites this paper
• Functionalized Biomimetic Calcium Phosphates for Bone Tissue Repair

  2017cites this paper
• Hydroxyapatite functionalization to trigger adsorption and release of risedronate.

  2017cites this paper
• A straightforward approach to enhance the textural, mechanical and biological properties of injectable calcium phosphate apatitic cements (CPCs): CPC/blood composites, a comprehensive study.

  2017cites this paper
• A single CT-guided percutaneous intraosseous injection of thermosensitive simvastatin/poloxamer 407 hydrogel enhances vertebral bone formation in ovariectomized minipigs

  2016cites this paper
• Delivery of pharmaceutics to bone: nanotechnologies, high-throughput processing and in silico mathematical models

  2016cites this paper
• Exosomes Secreted by Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Repair Critical-Sized Bone Defects through Enhanced Angiogenesis and Osteogenesis in Osteoporotic Rats

  2016cites this paper
• Composite Hydrogels for Bone Regeneration

  2016cites this paper
• Ordered mesoporous magnesium silicate with uniform nanochannels as a drug delivery system: The effect of calcination temperature on drug delivery rate

  2016cites this paper
• The blood-tendon barrier: identification and characterisation of a novel tissue barrier in tendon blood vessels.

  2016cites this paper
• Can we induce osteoporosis in animals comparable to the human situation?

  2016cites this paper
• Alendronate Functionalized Mesoporous Bioactive Glass Nanospheres

  2016cites this paper
• Bisphosphonates: therapeutics potential and recent advances in drug delivery

  2015cites this paper
• Bone augmentation using a new injectable bone graft substitute by combining calcium phosphate and bisphosphonate as composite—an animal model

  2015cites this paper
• Design and properties of novel gallium-doped injectable apatitic cements.

  2015cites this paper
• Local drug delivery for enhancing fracture healing in osteoporotic bone.

  2015cites this paper
• Análise histomorfométrica do reparo ósseo em tíbias de ratas tratadas com ácido zolendrônico

  2015cites this paper
• Gallium, a promising candidate for bone pathologies treatment

  2015cites this paper
• Gallium, un candidat prometteur pour le traitement des pathologies osseuses

  2015cites this paper
• Drug Delivery Strategies for Treating Osteoporosis

  2014cites this paper
• In vitro degradability, bioactivity and cell responses to mesoporous magnesium silicate for the induction of bone regeneration.

  2014cites this paper
• Vertebroplasty using bisphosphonate-loaded calcium phosphate cement in a standardized vertebral body bone defect in an osteoporotic sheep model.

  2014cites this paper
• The relevance of biomaterials to the prevention and treatment of osteoporosis.

  2014cites this paper
• Tissue engineering scaffolds of mesoporous magnesium silicate and poly(ε-caprolactone)–poly(ethylene glycol)–poly(ε-caprolactone) composite

  2014cites this paper
• Local injection of a single dose of simvastatin augments osteoporotic bone mass in ovariectomized rats

  2014cites this paper
• Is bisphosphonate therapy compromised by the emergence of adverse bone disorders?

  2014cites this paper
• Adipogenic differentiation potential of adipose‐derived mesenchymal stem cells from ovariectomized mice

  2014cites this paper
• Biomaterial Thin Films by Soft Pulsed Laser Technologies for Biomedical Applications

  2014cites this paper
• Sheep model for osteoporosis: Sustainability and biomechanical relevance of low turnover osteoporosis induced by hypothalamic–pituitary disconnection

  2013cites this paper
• Enhanced osteoporotic bone regeneration by strontium-substituted calcium silicate bioactive ceramics.

  2013cites this paper
• Biomimetic preparation of trace element-codoped calcium phosphate for promoting osteoporotic bone defect repair.

  2013cites this paper
• Exploring drug delivery systems for treating osteoporosis

  2013cites this paper
• Biomedical applications of bisphosphonates.

  2013cites this paper
• An In Vitro Assessment of Fibroblast and Osteoblast Response to Alendronate-Modified Titanium and the Potential for Decreasing Fibrous Encapsulation

  2013cites this paper
• Progress on the preparation of nanocrystalline apatites and surface characterization: Overview of fundamental and applied aspects

  2013cites this paper
• Bisphosphonates induce the osteogenic gene expression in co-cultured human endothelial and mesenchymal stem cells

  2013cites this paper
• Bone Formation Analysis: Effect of Quantification Procedures on the Study Outcome

  2012cites this paper
• The role of small molecules in musculoskeletal regeneration.

  2012cites this paper
• Large animal model for osteoporosis in humans: the ewe.

  2012cites this paper
• The effect of alendronate doped calcium phosphates on bone cells activity.

  2012cites this paper
• Nanoparticles of cobalt-substituted hydroxyapatite in regeneration of mandibular osteoporotic bones

  2012cites this paper
• Gallium as a potential candidate for treatment of osteoporosis.

  2012cites this paper
• Controlling the biological function of calcium phosphate bone substitutes with drugs.

  2012cites this paper
• Delivery of PDGF-B and BMP-7 by mesoporous bioglass/silk fibrin scaffolds for the repair of osteoporotic defects.

  2012cites this paper
• The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro.

  2012cites this paper
• Surface modification using phosphonic acids and esters.

  2012cites this paper
• Designing calcium phosphate-based bifunctional nanocapsules with bone-targeting properties

  2012cites this paper
• Transplantable delivery systems for in situ controlled release of bisphosphonate in orthopedic therapy

  2011cites this paper
• Characterization and properties of novel gallium-doped calcium phosphate ceramics.

  2011cites this paper
• Gallium-Doped β-Tricalcium Phosphate Ceramics: Characterization and Properties

  2011cites this paper
• Investigation of alendronate-doped apatitic cements as a potential technology for the prevention of osteoporotic hip fractures: critical influence of the drug introduction mode on the in vitro cement properties.

  2011cites this paper
• Hydroxyapatite functionalization to trigger adsorption and release of risedronate

  year unknowncites this paper